Login to Your Account

Other News To Note

Wednesday, January 16, 2013
• Opexa Therapeutics Inc., of The Woodlands, Texas, said it was notified by Nasdaq that it has regained full compliance with the minimum bid price continued listing requirement.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription